Effect of 2% Chlorhexidine on Shear Bond Strength of Composite Resins to Dentin

Abstract Background and Aim: Intracanal medicaments can affect the bond strength of composite to dentin. The aim of this study was to evaluate the effect of 2% chlorhexidine (CHX) gel as an intracanal medicament on shear bond strength of three different composite resins to dentin. Materials and Methods: In this in-vitro study, 60 intact extracted human premolars were utilized. Each tooth was sectioned vertically and dentin of the buccal surface was exposed. Then, specimens were divided into six groups of 10 teeth. In groups 1-3, dentin was exposed to CHX and in groups 4-6, dentin was exposed to saline. All prepared surfaces were rinsed with distilled water and dentin bonding agent specific for each composite was applied on the dentin surfaces. Z100, Z350 and P90 composites were applied to the treated surfaces and cured. The shear bond strength was recorded in Newtons and converted to MPa. Data were analyzed using the Kruskal-Wallis and Dunn tests. Results: The lowest mean shear bond strength was reported for normal saline and Z100 composite group (18.47 MPa) and the highest for CHX and Z350 group (42.26 MPa). No statistically significant difference in bond strength values was found between normal saline and CHX groups (P>0.05). There was a significant difference in bond strength values of different composite resins in normal saline (P<0.05) and also in CHX groups (P<0.05). Conclusion: Application of 2% chlorhexidine gel slightly but not significantly increases the mean shear bond strength of composite to dentin. The type of composite influences the shear bond strength to denti

The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019

BACKGROUND: Communicable disease control has long been a focus of global health policy. There have been substantial reductions in the burden and mortality of communicable diseases among children younger than 5 years, but we know less about this burden in older children and adolescents, and it is unclear whether current programmes and policies remain aligned with targets for intervention. This knowledge is especially important for policy and programmes in the context of the COVID-19 pandemic. We aimed to use the Global Burden of Disease (GBD) Study 2019 to systematically characterise the burden of communicable diseases across childhood and adolescence. METHODS: In this systematic analysis of the GBD study from 1990 to 2019, all communicable diseases and their manifestations as modelled within GBD 2019 were included, categorised as 16 subgroups of common diseases or presentations. Data were reported for absolute count, prevalence, and incidence across measures of cause-specific mortality (deaths and years of life lost), disability (years lived with disability [YLDs]), and disease burden (disability-adjusted life-years [DALYs]) for children and adolescents aged 0-24 years. Data were reported across the Socio-demographic Index (SDI) and across time (1990-2019), and for 204 countries and territories. For HIV, we reported the mortality-to-incidence ratio (MIR) as a measure of health system performance. FINDINGS: In 2019, there were 3·0 million deaths and 30·0 million years of healthy life lost to disability (as measured by YLDs), corresponding to 288·4 million DALYs from communicable diseases among children and adolescents globally (57·3% of total communicable disease burden across all ages). Over time, there has been a shift in communicable disease burden from young children to older children and adolescents (largely driven by the considerable reductions in children younger than 5 years and slower progress elsewhere), although children younger than 5 years still accounted for most of the communicable disease burden in 2019. Disease burden and mortality were predominantly in low-SDI settings, with high and high-middle SDI settings also having an appreciable burden of communicable disease morbidity (4·0 million YLDs in 2019 alone). Three cause groups (enteric infections, lower-respiratory-tract infections, and malaria) accounted for 59·8% of the global communicable disease burden in children and adolescents, with tuberculosis and HIV both emerging as important causes during adolescence. HIV was the only cause for which disease burden increased over time, particularly in children and adolescents older than 5 years, and especially in females. Excess MIRs for HIV were observed for males aged 15-19 years in low-SDI settings. INTERPRETATION: Our analysis supports continued policy focus on enteric infections and lower-respiratory-tract infections, with orientation to children younger than 5 years in settings of low socioeconomic development. However, efforts should also be targeted to other conditions, particularly HIV, given its increased burden in older children and adolescents. Older children and adolescents also experience a large burden of communicable disease, further highlighting the need for efforts to extend beyond the first 5 years of life. Our analysis also identified substantial morbidity caused by communicable diseases affecting child and adolescent health across the world. FUNDING: The Australian National Health and Medical Research Council Centre for Research Excellence for Driving Investment in Global Adolescent Health and the Bill & Melinda Gates Foundation

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic

HISTOLOGIC AND RADIOGRAPHIC COMPARISON OF MTA AND CA(OH)2 MATERIALS FOR APEXOGENESIS IN OPEN APEX CAT CANINE TEETH

Introduction. One of the problems encounted in endodontic treatment is the treatment of vital open apex teeth. Among different materials used for this purpose, Calcium hydroxide is the most widly used material. The purpose of this study was to compare a newly introduced material called MTA (Mineral Trioxide Aggregate) with calcium hydroxide in apexogenesis procedure.&#13; Methods: Fourty open apex canine teeth of 10 young cats were used in this study. Crowns of the teeth were resected and access cavities were slightly extended. Floor of pulp chamber of 16 teeth were packed with MTA and that of the other 16 teeth with Ca(OH)2.Access cavities were double sealed using ZOE and Amalgam. After 4-6 months the animals were sacrificed and the pulp and periodical tissues were examined by histologic evaluation.&#13; Four intact teeth were also used as negative control and 4 teeth without coronal seal were used as positive control.&#13; Results. Radiographic evaluation of MTA treated teeth after six months indicated that the apex of all of the teeth were closed and no calcified bridge was observed. In contrast, the apex of 13 out of 16 teeth treated with Ca(OH)2 had been closed and in calcium hydroxide samples calcified bridge had been formed. Histologically, there was a significant difference in microscopic changes of the pulp between the two treatment groups (P&lt;0.05). The pulp of the teeth with MTA was similar to that of a normal teeth and they showed no calcified bridge. Furthermore, histologic investigation of the periapical area showed no statistically significant difference between the two groups.&#13; Discussion: Based on the results obtained in this study and the previous findings despite the fact that Ca(OH)2 may result in the apical closure because MTA causes less pulpal changes in apexogenesis need MTA treated teeth may not further root canal therapy. Therefore, MTA application is superior to Ca(OH)2 for apexogenesis procedures

Comparison of Irrigation Penetration into the Apical Part of Canals in Hand and Rotary Instrumentations

Introduction: The penetration of irrigating solution to the apical one third of canals and removal of debris are dependent on the final size of the instruments and instrumentation techniques used in the canals. The purpose of this study was to evaluate the effect of final instrument size, on irrigation penetration into the apical part of canals in hand K-file instrumentation versus rotary system of Hero 642.Methods and Materials: The mesiobuccal canals of 48 first mandibular molar teeth were selected for this study. The teeth were divided into 2 groups of 24 in each and the mesiobuccal canals were instrumented by hand K-file or rotary system of Hero 642 at 2 stages. After each stage, a contrast medium was injected into the canals and radiographs were taken by RVG system. The irrigation penetration was measured in radiographs by Diamax software. The data were analyzed using t – student test.Results: This study showed that instrumentation up to # 25 file is not enough for irrigation penetration into the apical area. Also by more flaring the canals, more irrigating solution penetrates into the apical part of canals (P 0 0.001), but the difference between hand and rotary systems was not statistically significant (P > 0.05).Discussion: According to this study, instrumentation up to # 30 file results in better irrigation penetration into the apical area. The flaring of the canals is essential for better cleaning and irrigation of apical area

Protective effect of ghrelin on acetaminophen-induced liver injury in rat

Ghrelin is a peptide that has protective effects on many tissues of the body. It has anti-inflammatory and anti-oxidant effects. Acetaminophen, a commonly used analgesic-antipyretic drug, has hepatotoxic side effects. The aim of this study was to evaluate the protective role of ghrelin in liver toxicity due to acetaminophen overdose. Thirty male rats were used in this study and divided into five groups. They were control, propylene-glycol (as a solvent of acetaminophen), acetaminophen, acetaminophen and NAC, acetaminophen and ghrelin groups. Tumor necrosis factor alpha (TNF-α), and hepatic enzymes, AST (aspartate aminotransferase) and ALT (alanine aminotransferase), were assessed and histologic study of liver were performed as indicators of liver damage following acetaminophen toxicity. Results showed that Ghrelin decreased ALT and AST to the normal level, and also reduced TNF-α. Although NAC (the standard antidote of acetaminophen toxicity) also reduced ALT, AST and TNF-α levels, our results show that ghrelin is more potent than NAC in protecting the liver from acetaminophen-induced liver injury. © 2010 Elsevier Inc. All rights reserved

A machine learning-based system for detecting leishmaniasis in microscopic images

Background Leishmaniasis, a disease caused by a protozoan, causes numerous deaths in humans each year. After malaria, leishmaniasis is known to be the deadliest parasitic disease globally. Direct visual detection of leishmania parasite through microscopy is the frequent method for diagnosis of this disease. However, this method is time-consuming and subject to errors. This study was aimed to develop an artificial intelligence-based algorithm for automatic diagnosis of leishmaniasis. Methods We used the Viola-Jones algorithm to develop a leishmania parasite detection system. The algorithm includes three procedures: feature extraction, integral image creation, and classification. Haar-like features are used as features. An integral image was used to represent an abstract of the image that significantly speeds up the algorithm. The adaBoost technique was used to select the discriminate features and to train the classifier. Results A 65 recall and 50 precision was concluded in the detection of macrophages infected with the leishmania parasite. Also, these numbers were 52 and 71, respectively, related to amastigotes outside of macrophages. Conclusion The developed system is accurate, fast, easy to use, and cost-effective. Therefore, artificial intelligence might be used as an alternative for the current leishmanial diagnosis methods

Photoluminescent carbon quantum dot/poly-L-Lysine core-shell nanoparticles: A novel candidate for gene delivery

Cationic polymers such as poly-L-lysine (PLL) are able to interact electrostatically with DNA to produce polymeric systems with nanometric diameters due to the neutralization and accumulation of DNA. This study integrates the outstanding properties of carbon quantum dots (CQDs) with PLL to develop a novel gene delivery vehicle with a core-shell hybrid nanostructure. The CQD/PLL core-shell nanoparticles (NPs) were, therefore, synthesized in such a way that they had narrow size distribution and an average diameter under 10 nm, both of which were confirmed by dynamic light scattering (DLS) and transmission electron microscopy (TEM). Fourier transform infrared (FTIR) spectroscopy exhibited that the PLL passivation agents were formed on the CQDs through releasing amine groups on their surface. The positive charge of the CQD/PLL core-shell NPs reduced from +15 to nearly zero mV after being loaded with DNA at the weight ratio of 2:1. These traceable, water-soluble, biocompatible, and tunable photoluminescent NPs demonstrated a quantum yield of around 12 and a cellular uptake of nearly 70. The NPs also showed no considerable toxicity to the human embryonic kidney (HEK)-293T cells. Hence, these novel CQD/PLL core-shell NPs hold great promise as a non-toxic and efficient gene delivery vector. © 2020 Elsevier B.V